• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Managed Care Minute: January 24, 2015

Video

A one-minute look back at the week of January 19, 2015, in managed care, including Marilyn Tavenner's departure from CMS and oncology drug pricing.

The top story in managed care this week was the news that Marilyn Tavenner would be resigning from her post as chief of CMS at the end of February. Andy Slavitt is slated to take over temporarily until Senate approves his appointment or another candidate is confirmed.

Although clinical trial results for Kite Pharma’s cancer immuno-therapy aren’t due until 2016, the company learned its lesson from last year’s price wars over Gilead’s hepatitis C treatment.

Lastly, we invite you to take a look at this month’s The American Journal of Managed Care as we kick off our 20th year of publication with a special commentary by co-editors-in-chief, A. Mark Fendrick, MD, and Michael E. Chernew, PhD.

Related Videos
Will Shapiro
Mila Felder, MD, FACEP
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Dr Kathi Mooney
Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.